AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 18%
#906 out of 5116 analysts
Average Return
+8.81%
Win Rate
41%39 out of 96
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+215.71%$9.80$30.94
2024-06-04 -
2025-06-03
Buy
Scholar Rock Holding CorpSRRK
+182.30%$10.79$30.46
2024-05-23 -
2025-05-22
Buy
Werewolf Therapeutics IncHOWL
+180.18%$2.17$6.08
2023-03-23 -
2024-03-22
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Novabridge BiosciencesNBP
1Buy$7.00+82.29%Reiterates
5 months ago
Immunitybio IncIBRX
4Buy$8.00+238.98%Reiterates
6 months ago
Aura Biosciences IncAURA
1Buy$22.00+233.33%Assumes
6 months ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+599.30%Reiterates
6 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+246.62%Maintains
7 months ago
Tscan Therapeutics IncTCRX
1Buy$10.00+800.90%Maintains
7 months ago
Erasca IncERAS
10Buy$6.00+89.27%Reiterates
7 months ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+173.68%Reiterates
7 months ago
Sutro Biopharma IncSTRO
1Hold$2.00+117.63%Reiterates
7 months ago
Protara Therapeutics IncTARA
1Buy$23.00+211.65%Reiterates
7 months ago
Cg Oncology IncCGON
13Buy$75.00+67.26%Reiterates
7 months ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+279.35%Reiterates
8 months ago
Mural Oncology PLCMURA
5Buy$6.00+195.57%Maintains
8 months ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+1,400.00%Reiterates
9 months ago
Engene Holdings IncENGN
2Buy$25.00+211.18%Reiterates
9 months ago
Scholar Rock Holding CorpSRRK
13Buy$50.00N/AMaintains
a year ago
Imagenebio IncIMA
11Buy$48.00N/AReiterates
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.